| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |